Benzodiazepine Use and HIV-Associated Neurocognitive Impairment: Which Comes First?
J Acquir Immune Defic Syndr
.
2020 Apr 1;83(4):e26-e27.
doi: 10.1097/QAI.0000000000002278.
Authors
Elisa Mantovani
1
,
Fabio Lugoboni
2
,
Angela Federico
1
,
Donato Zipeto
1
,
Stefano Tamburin
1
Affiliations
1
Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
2
Department of Medicine, Addiction Medicine Unit, Verona University Hospital, Verona, Italy.
PMID:
31914007
DOI:
10.1097/QAI.0000000000002278
No abstract available
Publication types
Letter
MeSH terms
Benzodiazepines / adverse effects*
HIV Infections / complications*
HIV Infections / pathology
HIV-1
Humans
Neurocognitive Disorders / chemically induced*
Neurocognitive Disorders / etiology*
Substances
Benzodiazepines